Welcome to CDC stacks | Glucose Control Predicts 2-Year Change in Lipid Profile in Youth with Type 1 Diabetes - 33638 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
Clear All Simple Search
Advanced Search
Glucose Control Predicts 2-Year Change in Lipid Profile in Youth with Type 1 Diabetes
Filetype[PDF-358.14 KB]

  • Pubmed ID:
  • Pubmed Central ID:
  • Description:

    To test the hypothesis that a change in A1c over a follow-up interval of approximately 2 years would be associated with concomitant changes in fasting lipids in individuals with type 1 diabetes (T1D).

    Study design

    All subjects with T1D diagnosed 2002–2005 in the SEARCH for Diabetes in Youth study with at least two study visits approximately 12 and 24-months after an initial visit were included (age at initial visit=10.6±4.1 years, 48% female, diabetes duration=10±7 months, 76% non-Hispanic White, A1c=7.7±1.4%). Longitudinal mixed models were fit to examine the relationship between change in A1c and change in lipid levels (total cholesterol [TC], high-density lipoprotein-cholesterol [HDL-c], low-density lipoprotein-cholesterol [LDL-c], log triglycerides [TG], and non-high-density lipoprotein-cholesterol [non-HDL-c]) with adjustment for possible confounders.


    Change in A1c over time was significantly associated with changes in TC, HDL-c, LDL-c, TG, and non-HDL-c over the range of A1c values. For example, for a person with an A1c of 10% and then a 2% decrease in A1c 2-years later (to 8%), the model predicted concomitant changes in TC (−0.29 mmol/l, −11.4 mg/dl), HDL-c (0.03 mmol/l, 1.3 mg/dl), LDL-c (−0.23 mmol/l, −9.0 mg/dl), and non-HDL-c (−0.32 mmol/l, −12.4 mg/dl), and an 8.5% decrease in TG (mmol/l).


    Improved glucose control over a 2-year follow-up was associated with a more favorable lipid profile, but may be insufficient to normalize lipids in dyslipidemic T1D youth needing to decrease lipids to goal.

  • Document Type:
  • Collection(s):
  • Funding:
    1U18DP002709/DP/NCCDPHP CDC HHS/United States
    1UL1RR026314-01/RR/NCRR NIH HHS/United States
    K23 DK075360/DK/NIDDK NIH HHS/United States
    M01 RR00069/RR/NCRR NIH HHS/United States
    M01RR00037/RR/NCRR NIH HHS/United States
    P30 DK048520/DK/NIDDK NIH HHS/United States
    P30 DK57516/DK/NIDDK NIH HHS/United States
    U01 DP000246/DP/NCCDPHP CDC HHS/United States
    U01 DP000247/DP/NCCDPHP CDC HHS/United States
    U01 DP000248/DP/NCCDPHP CDC HHS/United States
    U01 DP000250/DP/NCCDPHP CDC HHS/United States
    U01DP000245/DP/NCCDPHP CDC HHS/United States
    U18DP000247-06A1/DP/NCCDPHP CDC HHS/United States
    U18DP002714/DP/NCCDPHP CDC HHS/United States
    U48/CCU519239/PHS HHS/United States
    U48/CCU819241-3/PHS HHS/United States
    U48/CCU919219/PHS HHS/United States
    U58/CCU919219/PHS HHS/United States
    U58CCU919256/PHS HHS/United States
    UL1 TR000077/TR/NCATS NIH HHS/United States
    UL1RR029882/RR/NCRR NIH HHS/United States
No Related Documents.
You May Also Like: